{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T16:18:28Z","timestamp":1778689108838,"version":"3.51.4"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T00:00:00Z","timestamp":1527552000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2014-1164"],"award-info":[{"award-number":["2014-1164"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["11423"],"award-info":[{"award-number":["11423"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["TRANS-ALS project"],"award-info":[{"award-number":["TRANS-ALS project"]}],"id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["TRANS-ALS project"],"award-info":[{"award-number":["TRANS-ALS project"]}],"id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Union under the Marie Curie International Reintegration Grant","award":["PIRG08-GA-2010-277008"],"award-info":[{"award-number":["PIRG08-GA-2010-277008"]}]},{"name":"The European Community's Health Seventh Framework Programme","award":["FP7\/2007-2013 under grant agreement no. 259867"],"award-info":[{"award-number":["FP7\/2007-2013 under grant agreement no. 259867"]}]},{"name":"The European Community's Health Seventh Framework Programme","award":["FP7\/2007-2013 under grant agreement no. 259867"],"award-info":[{"award-number":["FP7\/2007-2013 under grant agreement no. 259867"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0198089","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T17:31:53Z","timestamp":1527615113000},"page":"e0198089","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":22,"title":["Micro-computed tomography for non-invasive evaluation of muscle atrophy in mouse models of disease"],"prefix":"10.1371","volume":"13","author":[{"given":"Laura","family":"Pasetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Olivari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Nardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Trolese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Bendotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-9352","authenticated-orcid":true,"given":"Rosanna","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-2054","authenticated-orcid":true,"given":"Valentina","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,5,29]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-010-5830-y","article-title":"Management of respiratory symptoms in ALS","volume":"258","author":"O Hardiman","year":"2011","journal-title":"J Neurol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3389\/fphys.2013.00356","article-title":"More than a bystander: the contributions of intrinsic skeletal muscle defects in motor neuron diseases","volume":"4","author":"JG Boyer","year":"2013","journal-title":"Front Physiol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/dvdy.24036","article-title":"Mechanisms of muscle growth and atrophy in mammals and Drosophila","volume":"243","author":"R Piccirillo","year":"2014","journal-title":"Dev Dyn"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1080\/15384101.2015.1010979","article-title":"Inactivating STAT3: bad for tumor, good for muscle","volume":"14","author":"R Piccirillo","year":"2015","journal-title":"Cell Cycle"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM200105313442207","article-title":"Amyotrophic lateral sclerosis","volume":"344","author":"LP Rowland","year":"2001","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/364362c0","article-title":"Mutations in Cu\/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis","volume":"364","author":"DR Rosen","year":"1993","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation","volume":"264","author":"ME Gurney","year":"1994","journal-title":"Science"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tips.2006.03.009","article-title":"Targets in ALS: designing multidrug therapies","volume":"27","author":"MT Carr\u00ec","year":"2006","journal-title":"Trends Pharmacol Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/bpa.12351","article-title":"New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models","volume":"26","author":"G Nardo","year":"2016","journal-title":"Brain Pathol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"JM Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2407-10-363","article-title":"Molecular, cellular and physiological characterization of the cancer cachexia-inducing C26 colon carcinoma in mouse","volume":"10","author":"P Aulino","year":"2010","journal-title":"BMC Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S0969-9961(03)00041-X","article-title":"Skeletal muscle properties in a transgenic mouse model for amyotrophic lateral sclerosis: effects of creatine treatment","volume":"13","author":"W Derave","year":"2003","journal-title":"Neurobiol Dis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"e112477","DOI":"10.1371\/journal.pone.0112477","article-title":"Non-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficits","volume":"9","author":"CR Heier","year":"2014","journal-title":"PloS One"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.expneurol.2011.05.007","article-title":"Hind limb muscle atrophy precedes cerebral neuronal degeneration in G93A-SOD1 mouse model of amyotrophic lateral sclerosis: a longitudinal MRI study","volume":"231","author":"S Marcuzzo","year":"2011","journal-title":"Exp Neurol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/mrm.26685","article-title":"MRI reveals therapeutical efficacy of stem cells: An experimental study on the SOD1(G93A) animal model","volume":"79","author":"P Bontempi","year":"2018","journal-title":"Magn Reson Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1007\/s12603-009-0204-9","article-title":"Sarcopenia: clinical evaluation, biological markers and other evaluation tools","volume":"13","author":"M Pahor","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00216-003-2224-3","article-title":"Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis","volume":"377","author":"GZ Taicher","year":"2003","journal-title":"Anal Bioanal Chem"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e79101","DOI":"10.1371\/journal.pone.0079101","article-title":"Combination of the c-Met inhibitor tivantinib and zoledronic acid prevents tumor bone engraftment and inhibits progression of established bone metastases in a breast xenograft model","volume":"8","author":"S Previdi","year":"2013","journal-title":"PloS One"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2014.07.013","article-title":"Contrast agents for preclinical targeted X-ray imaging","volume":"76","author":"X Li","year":"2014","journal-title":"Adv Drug Deliv Rev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.neurobiolaging.2014.06.026","article-title":"Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis","volume":"36","author":"M Marino","year":"2015","journal-title":"Neurobiol Aging"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17482960902803440","article-title":"Treatment with lithium carbonate does not improve disease progression in two different strains of SOD1 mutant mice","volume":"10","author":"C Pizzasegola","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e0132159","DOI":"10.1371\/journal.pone.0132159","article-title":"Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis","volume":"10","author":"I Caron","year":"2015","journal-title":"PloS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"6212","DOI":"10.1038\/onc.2016.153","article-title":"Activation of the SDF1\/CXCR4 pathway retards muscle atrophy during cancer cachexia","volume":"35","author":"GB Martinelli","year":"2016","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s12974-016-0732-2","article-title":"Immune response in peripheral axons delays disease progression in SOD1(G93A) mice","volume":"13","author":"G Nardo","year":"2016","journal-title":"J Neuroinflammation"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/emboj.2012.178","article-title":"The p97\/VCP ATPase is critical in muscle atrophy and the accelerated degradation of muscle proteins","volume":"31","author":"R Piccirillo","year":"2012","journal-title":"EMBO J"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2119\/2006-00045.Mennini","article-title":"Nonhematopoietic erythropoietin derivatives prevent motoneuron degeneration in vitro and in vivo","volume":"12","author":"T Mennini","year":"2006","journal-title":"Mol Med Camb Mass"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1093\/genetics\/43.5.835","article-title":"Acute Radiation Response of Mice from a Cross between Radiosensitive and Radioresistant Strains","volume":"43","author":"D Grahn","year":"1958","journal-title":"Genetics"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1126\/science.124.3231.1078","article-title":"Age, growth, and the LD50 of x-rays","volume":"124","author":"RF Kallman","year":"1956","journal-title":"Science"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ejmp.2014.05.011","article-title":"Micro-CT of rodents: state-of-the-art and future perspectives","volume":"30","author":"DP Clark","year":"2014","journal-title":"Phys Med"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1259\/0007-1285-30-349-40","article-title":"Quantitative observations on recovery from whole body irradiation in mice. II. Recovery during and after daily irradiation","volume":"30","author":"RH Mole","year":"1957","journal-title":"Br J Radiol"},{"key":"ref31","first-page":"174","article-title":"Genetic and tissue level muscle-bone interactions during unloading and reambulation","volume":"16","author":"S Judex","year":"2016","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/09553008114550731","article-title":"Late effects of whole or partial body x-irradiation on mice: life shortening","volume":"39","author":"F Sato","year":"1981","journal-title":"Int J Radiat Biol Relat Stud Phys Chem Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of Cancer Cachexia and Muscle Wasting by ActRIIB Antagonism Leads to Prolonged Survival","volume":"142","author":"X Zhou","year":"2010","journal-title":"Cell"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s13539-012-0078-2","article-title":"Biomarkers of sarcopenia in clinical trials-recommendations from the International Working Group on Sarcopenia","volume":"3","author":"M Cesari","year":"2012","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2174\/187152710791556096","article-title":"Unraveling the Complexity of Amyotrophic Lateral Sclerosis: Recent Advances from the Transgenic Mutant SOD1 Mice","volume":"9","author":"M Peviani","year":"2010","journal-title":"CNS Neurol Disord\u2014Drug Targets"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.expneurol.2003.10.004","article-title":"Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man","volume":"185","author":"LR Fischer","year":"2004","journal-title":"Exp Neurol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/nn1653","article-title":"Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF","volume":"9","author":"S Pun","year":"2006","journal-title":"Nat Neurosci"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1089\/ars.2012.4524","article-title":"Molecular signatures of amyotrophic lateral sclerosis disease progression in hind and forelimb muscles of an SOD1(G93A) mouse model","volume":"17","author":"D Capitanio","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000085063","article-title":"Mitochondria in amyotrophic lateral sclerosis: a trigger and a target","volume":"1","author":"L Dupuis","year":"2004","journal-title":"Neurodegener Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physiolgenomics.00017.2007","article-title":"Gene profiling of skeletal muscle in an amyotrophic lateral sclerosis mouse model","volume":"32","author":"J-L Gonzalez de Aguilar","year":"2007","journal-title":"Physiol Genomics"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of SOD1G93A-mediated toxicity","volume":"8","author":"G Dobrowolny","year":"2008","journal-title":"Cell Metab"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","article-title":"Skeletal Muscle-Restricted Expression of Human SOD1 Causes Motor Neuron Degeneration in Transgenic Mice","volume":"19","author":"M Wong","year":"2010","journal-title":"Hum Mol Genet"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.nbd.2006.12.023","article-title":"Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death","volume":"26","author":"M Dewil","year":"2007","journal-title":"Neurobiol Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1523\/JNEUROSCI.1139-07.2007","article-title":"Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model","volume":"27","author":"C Rouaux","year":"2007","journal-title":"J Neurosci"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1523\/JNEUROSCI.20-07-02534.2000","article-title":"Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases","volume":"20","author":"D Frey","year":"2000","journal-title":"J Neurosci"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"K Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1133S","DOI":"10.3945\/ajcn.2010.28608C","article-title":"Body composition in patients with non-small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis","volume":"91","author":"VE Baracos","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"ref48","first-page":"365","article-title":"Weight loss versus muscle loss: re-evaluating inclusion criteria for future cancer cachexia interventional trials","volume":"25","author":"EJ Roeland","year":"2017","journal-title":"Support Care Cancer Off J Multinatl Assoc Support Care Cancer"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1470-2045(08)70153-0","article-title":"Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study","volume":"9","author":"CMM Prado","year":"2008","journal-title":"Lancet Oncol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijcard.2012.09.213","article-title":"Cachexia as major underestimated unmet medical need: facts and numbers","volume":"161","author":"S von Haehling","year":"2012","journal-title":"Int J Cardiol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/SPC.0b013e3282f31667","article-title":"How does cachexia influence survival in cancer, heart failure and other chronic diseases?","volume":"1","author":"M Lainscak","year":"2007","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/SPC.0b013e32834c49ba","article-title":"Understanding cancer-induced cachexia: imaging the flame and its fuel","volume":"5","author":"M-F Penet","year":"2011","journal-title":"Curr Opin Support Palliat Care"},{"key":"ref53","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18050986","article-title":"Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors","volume":"18","author":"FO Villars","year":"2017","journal-title":"Int J Mol Sci"},{"key":"ref54","article-title":"The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia","author":"A Bonetto","year":"2016","journal-title":"J Vis Exp JoVE"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1096\/fj.12-222844","article-title":"Diaphragm and ventilatory dysfunction during cancer cachexia","volume":"27","author":"BM Roberts","year":"2013","journal-title":"FASEB J"},{"key":"ref56","first-page":"1321","article-title":"Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice","volume":"39","author":"M Tian","year":"2011","journal-title":"Int J Oncol"},{"key":"ref57","first-page":"679","article-title":"Differential Bone Loss in Mouse Models of Colon Cancer Cachexia","volume":"7","author":"A Bonetto","year":"2016","journal-title":"Front Physiol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.18632\/oncotarget.2812","article-title":"Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle","volume":"6","author":"F Pretto","year":"2015","journal-title":"Oncotarget"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0198089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T20:47:19Z","timestamp":1751662039000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0198089"}},"subtitle":[],"editor":[{"given":"David R.","family":"Borchelt","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,5,29]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0198089","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,29]]}}}